Related Experiment Video
Updated: Aug 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon]
Yin-tang Jia1, Lai Wei, Dong Jiang
1Institute of Hepatology, People's Hospital, Peking University, Beijing 100044, China.
Objective:
To investigate the inhibitory effects of interferon-alpha (IFN-alpha) on HCV replicon and evaluate the expressing levels of signal transducer and activator of transcription genes (STAT1 and STAT2) and IFN-alpha stimulated genes (ISGs) which may mediate the inhibitory effects of IFN-alpha on HCV.
Methods:
Firstly HCV replicon cell culture system was established by transfecting HCV replicon RNA transcribed in vitro into Huh7 cells and screening with G418. Secondly, the established HCV replicon cells were treated with various concentrations of IFN-alpha (0, 10, 25, 50, 100, 250, 500, 750, 1000, 2500, and 5000 IU/ml) for 72 h or treated with 1000 IU/ml of IFN-alpha for different lengths of time (0, 24, 48, 72, 96 h), then the levels of HCV RNA and NS5A protein in these cells were examined by semi-quantitative RT-PCR and Western blot respectively.
Results:
IFN-alpha could effectively inhibit HCV RNA replication. 10 IU/ml or 25 IU/ml of IFN-alpha could lead to about 68% and 75% of HCV-RNA reduction respectively. The cells treated with 1000 IU/ml IFN-alpha for 24 h or 96 h had about 75% and 88% of HCV RNA reduction compared with the cells of control, demonstrated that the inhibitory effects of IFN-alpha on HCV replicon are in dose and time dependent manners. The expressions of antiviral ISGs-PKR, 2'5'OAS, G1P3, ISG20 and ISGF3gamma are strongly induced by IFN-alpha.
Conclusions:
HCV replicons were sensitive to IFN-alpha treatment. The inhibitory effects of IFN-alpha on HCV RNA and NS5A are both dose and time dependents. PKR, 2'5'OAS, G1P3, ISG20 and ISGF3gamma may mediate the inhibitory effects of IFN-alpha on HCV replicon replication.
Insights
Interferon-alpha (IFN-alpha) effectively inhibits Hepatitis C Virus (HCV) replication in a dose- and time-dependent manner. Key interferon-stimulated genes (ISGs) like PKR and 2'5'OAS are induced, potentially mediating this antiviral effect.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Context:
- Hepatitis C Virus (HCV) poses a significant global health challenge.
- Interferon-alpha (IFN-alpha) is a known antiviral cytokine.
- Understanding the precise mechanisms of IFN-alpha's efficacy against HCV is crucial for developing effective therapies.
Purpose:
- To investigate the inhibitory effects of IFN-alpha on HCV replication.
- To evaluate the expression of signal transducer and activator of transcription (STAT) genes and IFN-alpha stimulated genes (ISGs).
- To elucidate the role of STAT and ISG genes in mediating IFN-alpha's antiviral activity against HCV.
Summary:
- IFN-alpha demonstrated significant inhibition of HCV RNA replication and NS5A protein levels in a replicon system.
- The antiviral effects were observed to be both dose-dependent and time-dependent.
- IFN-alpha treatment strongly induced the expression of antiviral ISGs, including PKR, 2'5'OAS, G1P3, ISG20, and ISGF3gamma.
Impact:
- This study confirms the sensitivity of HCV replicons to IFN-alpha.
- Identifies specific ISGs (PKR, 2'5'OAS, G1P3, ISG20, ISGF3gamma) as potential mediators of IFN-alpha's antiviral effects.
- Provides insights into the molecular mechanisms underlying IFN-alpha therapy for HCV, potentially informing future treatment strategies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Hepatitis
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes
Antiviral Nucleoside Inhibitors

